1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Malignant Glioma Global Clinical Trials Review, H1, 2014

Malignant Glioma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Glioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Malignant Glioma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Malignant Glioma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Malignant Glioma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Malignant Glioma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Malignant Glioma 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Malignant Glioma Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Malignant Glioma 33
Nov 19, 2012: Aeterna Zentaris Announces Positive Data From Phase I Trial Of Perifosine Combined With Temsirolimus In Malignant Glioma 33
May 27, 2010: Announcement of initiation of Phase III clinical study of orally active in vivo diagnostic agent 33
for malignant glioma 33
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Merck and Co., Inc. 35
Clinical Trial Overview of Merck and Co., Inc. 35
Insys Therapeutics, Inc. 36
Clinical Trial Overview of Insys Therapeutics, Inc. 36
Eisai Co., Ltd. 37
Clinical Trial Overview of Eisai Co., Ltd. 37
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Sanofi 39
Clinical Trial Overview of Sanofi 39
Tactical Therapeutics, Inc 40
Clinical Trial Overview of Tactical Therapeutics, Inc 40
GlaxoSmithKline plc 41
Clinical Trial Overview of GlaxoSmithKline plc 41
Celgene Corporation 42
Clinical Trial Overview of Celgene Corporation 42
Amgen Inc. 43
Clinical Trial Overview of Amgen Inc. 43
Advantagene, Inc. 44
Clinical Trial Overview of Advantagene, Inc. 44
Clinical Trial Overview of Top Institutes / Government 45
National Cancer Institute 45
Clinical Trial Overview of National Cancer Institute 45
Duke University 49
Clinical Trial Overview of Duke University 49
Memorial Sloan Kettering Cancer Center 51
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 51
North American Brain Tumor Consortium 52
Clinical Trial Overview of North American Brain Tumor Consortium 52
The University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 53
UCLA's Jonsson Comprehensive Cancer Center 54
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 54
Northwestern University 55
Clinical Trial Overview of Northwestern University 55
NCIC Clinical Trials Group 56
Clinical Trial Overview of NCIC Clinical Trials Group 56
European Organization for Research and Treatment of Cancer 57
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 57
Five Key Clinical Profiles 58
Appendix 90
Abbreviations 90
Definitions 90
Research Methodology 91
Secondary Research 91
About GlobalData 92
Contact Us 92
Disclaimer 92
Source 93

List of Tables
Malignant Glioma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Malignant Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Malignant Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Malignant Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Malignant Glioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Malignant Glioma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Malignant Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Malignant Glioma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Malignant Glioma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Malignant Glioma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Malignant Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Malignant Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Malignant Glioma Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Malignant Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Malignant Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Malignant Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Malignant Glioma Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Malignant Glioma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Malignant Glioma Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Malignant Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Malignant Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Malignant Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Malignant Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Malignant Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 35
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Insys Therapeutics, Inc., 2014* 36
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 37
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 38
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 39
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tactical Therapeutics, Inc, 2014* 40
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 41
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 42
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 43
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Advantagene, Inc., 2014* 44
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 45
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 49
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 51
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by North American Brain Tumor Consortium, 2014* 52
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 53
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014* 54
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 55
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2014* 56
Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 57

List of Figures
Malignant Glioma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Malignant Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Malignant Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Malignant Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Malignant Glioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Malignant Glioma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Malignant Glioma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Malignant Glioma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Malignant Glioma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Malignant Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Malignant Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Malignant Glioma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Malignant Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Malignant Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Malignant Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Malignant Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Malignant Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Malignant Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Malignant Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Brain Cancer: Analytical Tool

Brain Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Glioblastoma Multiforme-Market Insights, Epidemiology and Market Forecast-2023

Glioblastoma Multiforme-Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Glioblastoma Multiforme - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • November 2016
    74 pages
  • Cancer  

  • United States  

View report >

Cancer Statistics and Therapy Market in the US - Forecast

  • November 2016
    52 pages
  • Cancer  

    Therapy  

  • United States  

View report >

Cancer Statistics in the US

  • October 2016
  • Cancer  

    Leukemia  

    Brain Cancer  

  • United States  

    North America  

View report >

Related Market Segments :

Brain Cancer
Therapy
Clinical Trial

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.